Considering the global emerging human pathogenic microbial diseases and trends, Human Pathogenic Microbes is framed to provide deep insights into the epidemic and emerging bacterial and fungal infections and diseases in humans. It presents novel, up-to-date, and cutting-edge knowledge regarding various human pathogenic microbes, their associated drug resistance mechanisms, and different diseases caused by them. Human Pathogenic Microbes reflects the current research and development on the evolution of bacterial and fungal drug resistance: different bacterial and fungal antimicrobial drug…mehr
Considering the global emerging human pathogenic microbial diseases and trends, Human Pathogenic Microbes is framed to provide deep insights into the epidemic and emerging bacterial and fungal infections and diseases in humans. It presents novel, up-to-date, and cutting-edge knowledge regarding various human pathogenic microbes, their associated drug resistance mechanisms, and different diseases caused by them. Human Pathogenic Microbes reflects the current research and development on the evolution of bacterial and fungal drug resistance: different bacterial and fungal antimicrobial drug resistance mechanisms along with their biological and molecular aspects. In a nutshell, Human Pathogenic Microbes describes a various bacterial and fungal diseases caused by different human pathogenic microbes employing different drug resistance mechanisms and processes. It also highlights the novel emerging approaches (Immunological and combinatorial) that will aid to fight against such bacterial and fungal pathogens.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr. Manzoor Ahmad Mir holds a Master's Degree in Zoology from HNBG Central University and completed his Ph.D. in Immunology at Jawaharlal Nehru University, New Delhi, and CSIR-Institute of Microbial Technology, Chandigarh. His research focuses on Cancer Biology, Combination Therapy in Breast Cancer, and Tuberculosis Immunology. Dr. Mir has published over 50 high-impact research papers and book chapters, earning multiple awards and royalties. He has authored more than 15 books with international publishers like Elsevier and Springer-Nature. Dr. Mir serves on the editorial boards of prestigious journals and has been an invited speaker at numerous scientific conferences. He is a member of several scientific organizations, including the American Association of Cancer Research and the Royal British Society. He has received the TARE Fellowship and the SRFP-2019 from Indian science academies. Dr. Mir teaches Cancer Biology and Immunology at the University of Kashmir, where he heads the Department of Bioresources.
Inhaltsangabe
1. Human Pathogenic Microbes (Bacterial and Fungal) and associated diseases 2. Evolution of Antimicrobial drug resistance in human pathogenic bacteria 3. Evolution of Antimicrobial drug resistance in human pathogenic fungi 4. Combating human bacterial infections: Need for new antibacterial drugs and therapies 5. Combating human fungal infections: Need for new antifungal drugs and therapies 6. Significance of immunotherapy for human bacterial diseases and antibacterial drug discovery 7. Significance of immunotherapy for human fungal diseases and antifungal drug discovery 8. Combinatorial approach to combat drug resistance in human pathogenic bacteria 9. Combinatorial approach to combat drug resistance in human pathogenic fungi 10. Recent trends in the development of bacterial and fungal vaccines
1. Human Pathogenic Microbes (Bacterial and Fungal) and associated diseases 2. Evolution of Antimicrobial drug resistance in human pathogenic bacteria 3. Evolution of Antimicrobial drug resistance in human pathogenic fungi 4. Combating human bacterial infections: Need for new antibacterial drugs and therapies 5. Combating human fungal infections: Need for new antifungal drugs and therapies 6. Significance of immunotherapy for human bacterial diseases and antibacterial drug discovery 7. Significance of immunotherapy for human fungal diseases and antifungal drug discovery 8. Combinatorial approach to combat drug resistance in human pathogenic bacteria 9. Combinatorial approach to combat drug resistance in human pathogenic fungi 10. Recent trends in the development of bacterial and fungal vaccines
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497